These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 25365403)

  • 1. Prognostic value of metastatic N1 lymph node ratio and angiolymphatic invasion in patients with pathologic stage IIA non-small cell lung cancer.
    Wu CF; Wu CY; Fu JY; Wang CW; Liu YH; Hsieh MJ; Wu YC
    Medicine (Baltimore); 2014 Oct; 93(20):e102. PubMed ID: 25365403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of the metastatic lymph node ratio for predicting the prognosis of non-small-cell lung cancer patients.
    Wang CL; Li Y; Yue DS; Zhang LM; Zhang ZF; Sun BS
    World J Surg; 2012 Feb; 36(2):455-62. PubMed ID: 22187129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of ratio-based lymph node staging in resected non-small-cell lung cancer.
    Qiu C; Dong W; Su B; Liu Q; Du J
    J Thorac Oncol; 2013 Apr; 8(4):429-35. PubMed ID: 23486264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].
    Li Y; Sun BS; Zhang ZF; Zhang LM; Wang CL
    Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1682-6. PubMed ID: 21914316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors for lymph node negative stage I and IIA non-small cell lung cancer: multicenter experiences.
    Oven Ustaalioglu BB; Unal OU; Turan N; Bilici A; Kaya S; Eren T; Ulas A; Inal A; Berk V; Demirci U; Alici S; Bal O; Benekli M; Gumus M
    Asian Pac J Cancer Prev; 2013; 14(11):6287-92. PubMed ID: 24377519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of metastatic N1 lymph nodes in completely resected non-small-cell lung cancer.
    Park S; Cho S; Yum SW; Kim K; Jheon S
    Interact Cardiovasc Thorac Surg; 2015 Nov; 21(5):624-9. PubMed ID: 26242319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection.
    Yoo C; Yoon S; Lee DH; Park SI; Kim DK; Kim YH; Kim HR; Choi SH; Kim WS; Choi CM; Jang SJ; Song SY; Kim SS; Choi EK; Lee JC; Suh C; Lee JS; Kim SW
    Clin Lung Cancer; 2015 Nov; 16(6):e203-12. PubMed ID: 25997733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of the extent of lymph node involvement in stage II-N1 non-small cell lung cancer.
    Li ZM; Ding ZP; Luo QQ; Wu CX; Liao ML; Zhen Y; Chen ZW; Lu S
    Chest; 2013 Oct; 144(4):1253-1260. PubMed ID: 23744276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortality.
    Solak M; Turkoz FP; Keskin O; Aksoy S; Babacan T; Sarici F; Kertmen N; Sever AR; Altundag K
    J BUON; 2015; 20(3):737-45. PubMed ID: 26214625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mediastinal downstaging after induction treatment is not a significant prognostic factor to select patients who would benefit from surgery: the clinical value of the lymph node ratio.
    Renaud S; Falcoz PE; Olland A; Reeb J; Santelmo N; Massard G
    Interact Cardiovasc Thorac Surg; 2015 Feb; 20(2):222-7. PubMed ID: 25413781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of fibrosis ratio in metastatic lymph nodes of node-positive advanced gastric cancer.
    Hong SA; Son MW; Cho J; Lee CH; Jang SH; Lee HJ; Lee JH; Cho HD; Oh MH; Lee KT; Lee MS
    Medicine (Baltimore); 2018 Jan; 97(3):e9703. PubMed ID: 29505025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival analysis of 220 patients with completely resected stage-II non-small cell lung cancer.
    Dai Y; Su XD; Long H; Lin P; Fu JH; Zhang LJ; Wang X; Wen ZS; Zhu ZH; Zhang X; Rong TH
    Chin J Cancer; 2010 May; 29(5):538-44. PubMed ID: 20426905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China.
    Li Z; Yu Y; Lu J; Luo Q; Wu C; Liao M; Zheng Y; Ai X; Gu L; Lu S
    J Thorac Oncol; 2009 Jun; 4(6):702-9. PubMed ID: 19404215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the lymph node ratio as a prognostic factor in patients with N1 nonsmall cell lung cancer.
    Jonnalagadda S; Arcinega J; Smith C; Wisnivesky JP
    Cancer; 2011 Oct; 117(20):4724-31. PubMed ID: 21452193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of the relationship between the anatomical location of intrapulmonary metastatic lymph nodes and relapse risk and survival in patients with N1 non-small cell lung cancer].
    Zhao DC; Yan S; Wang YQ; Ma YY; Wang X; Li SL; Li X; Lyu C; Wang YZ; Wang J; Yang Y; Wu N
    Zhonghua Yi Xue Za Zhi; 2021 Sep; 101(35):2778-2786. PubMed ID: 34551494
    [No Abstract]   [Full Text] [Related]  

  • 16. Lymph node ratio as an independent prognostic indicator in stage III colorectal cancer: especially for fewer than 12 lymph nodes examined.
    Jiang K; Zhu Y; Liu Y; Ye Y; Xie Q; Yang X; Wang S
    Tumour Biol; 2014 Nov; 35(11):11685-90. PubMed ID: 25139098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymph node ratio may predict the benefit of postoperative radiotherapy in non-small-cell lung cancer.
    Urban D; Bar J; Solomon B; Ball D
    J Thorac Oncol; 2013 Jul; 8(7):940-6. PubMed ID: 23695418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymph-node ratio predicts survival among the different stages of non-small-cell lung cancer: a multicentre analysis†.
    Chiappetta M; Leuzzi G; Sperduti I; Bria E; Mucilli F; Lococo F; Spaggiari L; Ratto GB; Filosso PL; Facciolo F
    Eur J Cardiothorac Surg; 2019 Mar; 55(3):405-412. PubMed ID: 30202953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of accurate hilar and intrapulmonary lymph node examination and prognostication in stage IA-IIA non-small cell lung cancer, a retrospective cohort study.
    Zhai W; Duan F; Zheng Y; Yan Q; Dai S; Chen T; Chen J; Wang J
    World J Surg Oncol; 2020 Sep; 18(1):258. PubMed ID: 32998771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymph node ratio predicts recurrence and survival after R0 resection for non-small cell lung cancer.
    Taylor MD; LaPar DJ; Thomas CJ; Persinger M; Stelow EB; Kozower BD; Lau CL; Jones DR
    Ann Thorac Surg; 2013 Oct; 96(4):1163-1170. PubMed ID: 23998409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.